US Stock MarketDetailed Quotes

ANAB AnaptysBio

Watchlist
  • 21.630
  • -0.550-2.48%
Close Oct 31 16:00 ET
  • 21.630
  • 0.0000.00%
Post 16:00 ET
653.22MMarket Cap-3406P/E (TTM)

About AnaptysBio Company

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

Company Profile

SymbolANAB
Company NameAnaptysBio
Listing DateJan 26, 2017
Issue Price15.00
Founded2005
CEOMr. Daniel R. Faga
MarketNASDAQ
Employees117
Fiscal Year Ends12-31
Address10770 Wateridge Circle,Suite 210
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121-5801
Phone1-858-362-6295
Websitehttp://www.anaptysbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel R. Faga
  • Director, President and Chief Executive Officer
  • 7.46M
  • Paul F. Lizzul, M.D.
  • Chief Medical Officer
  • 2.44M
  • Eric J. Loumeau
  • Chief Legal Officer
  • 2.26M
  • Dennis M. Mulroy
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • John A. Orwin
  • Chairman of the Board
  • 338.08K
  • Oleg Nodelman
  • Independent Director
  • --
  • John P. Schmid
  • Independent Director
  • 335.38K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 318.38K
  • Dr. J. Anthony Ware
  • Independent Director
  • 338.38K
  • Dr. Dennis M. Fenton,PhD
  • Independent Director
  • 331.88K
  • Hollings C. Renton
  • Independent Director
  • 342.38K
  • Dr. Rita I. Jain, M.D.
  • Independent Director
  • 495.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data